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Approximately 10% of patients presenting with extra-
cranial cerebrovascular disease have stenosis or ulcer-
ation of the proximal brachiocephalic arteries.1
Until recently the treatment of occlusive lesions of
the innominate artery has been surgical.1±3 Because of
high morbidity and mortality rates of up to 19%,4 that
has been increasing enthusiasm for transluminal
angioplasty and stenting.5±7
Patients and Methods
Five patients, 3 men, 2 women, mean age 64 years
(range: 47±79) with symptomatic stenosis of the
innominate artery presented between 1997 and 2000.
Indication for treatment was minor (3 patients) or
major (2) stroke and a stenosis of at least 50%. Con-
comitant risk factors were CAD in five, PAOD in four,
COPD and ipsilateral high grade stenosis of internal
carotid artery (ICA) in two, contralateral ICA stenosis
in one, hypertension in all the five, smoking in four
and hyperlipidaemia in three patients.
The combined surgical±angioplasty treatment was
performed under general anaesthesia. Femoral arterial
access was obtained using the Seldinger technique.
Diagnostic aortic arch and cervical angiograpy was
performed. The target vessel was studied in three
planes to measure the lesion and the reference diam-
eter of the innominate artery. Heparin (70 units per
kilogram) was administered.Please address all correspondence to: H. J. Lutz, Zentrum fuer
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anterior border of the sternocleidomastoid muscle.
Two vessel loops were placed around the CCA. After
stump pressure measurements, the distal CCA was
occluded with a clamp. An 8-F sheath (Terumo,
Tokyo, Japan) was then inserted over a guide wire.
The stenosis was crossed with the guide wire and
pre-dilatation with a 3 mm balloon was performed. A
balloon expandable stent (Palmaz, Cordis, Miami,
U.S.A.) was used. A stent size covering the entire
length of the stenosis was selected. The stent was
hand-mounted up to the reference diameter. Deflation
of the balloon for predilatation and for the stent im-
plantation was always preceded by opening of the
sheath to drain possible debris (Fig. 1). PostangioplastyFig. 1. Schematic figure of treatment.
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Hybrid Therapy of Symptomatic Stenosis 185angiograms were obtained. A residual stent waist of
less then 20% after angioplasty was deemed satisfac-
tory. In 2 cases an ipsilateral carotid endarterectomy
was performed, using patch closure of the arteriotomy.
Heparin administration was continued 24 h.
Aspirin (100 mg daily) and clopidogrel (75 mg
daily) were administered for 3 months, then aspirin
alone. The patients were followed up with duplex
ultrasound and clinical neurologic examinations
1 day and 3, 6 and 12 months after the procedure.
The patients will be followed up once a year.
Results
In all 5 cases technical and clinical success was
obtained. In two patients with high grade ipsilateral
ICA stenosis, surgical approach, endarterctomy and
patch angioplasty followed the angioplasty. Neither
neurological complications, nor mortality occured.
Postprocedural diffusion-weighted MR-imaging
revealed no embolic cerebral infarcts. In one patient
a local haematoma of the neck required surgical
evacuation. Mean hospital stay was 5,4 days.
Clinical followup of the patients was mean 18.6
months (range: 2±30 months). No neurological events
and no mortality were observed. One patient required
a transfemoral dilatation of an 80%, circular and
smooth in stent stenosis 12 months after initial treat-
ment. This procedure was performed uneventfully.
Discussion
In the last decades intraluminal angioplasty has estab-
lished itself in the treatment of occlusive vascular
disease. However there are still problems and severe
complications,8 such as early restenosis or occlusion,
embolisation or technical inability to perform angio-
plasty. Surgical therapy is highly invasive, carries sig-
nificant morbidity and mortality rates, results in
longer hospital stay and higher cost and is only indi-
cated in seleted cases. Percutaneous transfemoral
retrograde access offers a relatively safe alternative,9,10in cases where ulceration, total occlusion or cerebral
symptoms are not a problem.11 The method presented
here combines the advantages of intraluminal
approach and local surgical control with better brain
protection and is therefore a viable option in selected
patients with a high risk of periprocedural neuro-
logical complications.
Hybrid therapy of symptomatic stenosis of the
innominate artery offers an alternative either to
conventional surgical or purely percutaneous
approach especially in selected patients with a high
risk of cerebral embolisation. It can be performed with
technical success and low complication rate.
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